| 2D | two-dimensional |
| 4D-flow MRI | four-dimensional flow magnetic resonance imaging |
| ADMA | asymmetric dimethylarginine |
| AP | antero-posterior cusp fusion phenotype |
| AR | aortic valve regurgitation |
| AS | aortic valve stenosis |
| AVR | aortic valve replacement |
| BAVD | bicuspid aortic valve disease |
| BMP | bone morphogenic pathway |
| CD | color Doppler |
| CMR | cardiovascular magnetic resonance |
| CT | computed tomography |
| CTA | computed tomography angiography |
| CW | continuous wave Doppler |
| FGF | fibroblast growth factor |
| LL | latero-lateral cusp fusion phenotype |
| LN | left-non coronary cusp fusion phenotype |
| LVEDV | left ventricular end-diastolic volume |
| LVESV | left ventricular end-systolic volume |
| MLR | monocyte-to-lymphocyte ratio |
| MMP | matrix metalloproteinase |
| MRI | magnetic resonance imaging |
| PIV | pan-immune-inflammation value |
| PW | blood tissue pulse wave Doppler |
| RL | right-left cusp fusion phenotype |
| RN | right-non-coronary cusp fusion phenotype |
| SIRI | Systemic Inflammatory Response Index |
| sRAGE | soluble receptor for advanced glycation end-products |
| TAV | tricuspid aortic valve |
| TAVI | transcatheter aortic valve implantation |
| TGF-β | transforming growth factor-β |
| TIMP | tissue inhibitor of metalloproteinase |
| TTE | transthoracic echocardiography |
| Wnt | wingless-related MMTV integration sites |
| WSS | wall shear stress |